The reactions involved in the bacterial metabolism of naphthalene to salicylate have been reinvestigated by using recombinant bacteria carrying genes cloned from plasmid NAH7. When intact cells of Pseudomonas aeruginosa PAO1 carrying DNA fragments encoding the first three enzymes of the pathway were incubated with naphthalene, they formed products of the dioxygenase-catalyzed ring cleavage of 1,2-dihydroxynaphthalene. These products were separated by chromatography on Sephadex G-25 and were identified by 'H and 13C nuclear magnetic resonance spectroscopy and gas chromatography-mass spectrometry as 2-hydroxychromene-2-carboxylate (HCCA) and trans-o-hydroxybenzylidenepyruvate (tHBPA Naphthalene is the simplest fused polycyclic aromatic hydrocarbon. Information obtained from studies of bacterial degradation of naphthalene has been valuable for understanding and predicting the pathways used in the metabolism of the structurally more complex polycyclic aromatic hydrocarbons and related heterocyclic aromatic compounds. However, much about the bacterial metabolism of naphthalene has remained unclear, in particular the steps in the pathway by which 1,2-dihydroxynaphthalene (Fig. 1, compound III) is metabolized to salicylate.In the currently accepted naphthalene metabolic pathway ( Fig. 1) (3, 42, 53), 1,2-dihydroxynaphthalene is cleaved by a dioxygenase (Fig. 1, enzyme C) to an unstable ring cleavage product (Fig. 1, compound V), which spontaneously recyclizes to 2-hydroxychromene-2-carboxylate (HCCA) (compound VII). This compound is subsequently converted by means of an isomerase (enzyme D) to cis-o-hydroxybenzylidenepyruvate (cHBPA) (compound VII), which is cleaved by an aldolase (enzyme E), yielding salicylaldehyde and pyruvate. An NAD+-requiring aldehyde dehydrogenase then transforms salicylaldehyde to salicylate. This pathway for the metabolism of 1,2-dihydroxynaphthalene is based primarily on the work of Barnsley (3) and differs from the pathway proposed earlier by Davies and Evans (7), in which the unstable ring cleavage product (compound V) is rearomatized to give cHBPA (compound VIII), which is then metabolized in two sequential steps (hydration followed by aldol cleavage to salicylaldehyde Davies and Evans (7) and Barnsley (3) reached these different conclusions despite taking similar experimental approaches. These workers incubated cell extracts with low concentrations of 1,2-dihydroxynaphthalene for a short time and then rapidly took steps to purify and stabilize the product. Davies and Evans made the perchlorate derivative, which they crystallized, while Barnsley separated the product from cell extracts by chromatography on Sephadex G-25 followed by freeze-drying. Both Davies and Evans (7) and Barnsley (3) obtained HCCA. Barmsley identified this compound as the initial product of ring cleavage, but Davies and Evans recognized it as the hemiacetal (actually the hemiketal) of cHBPA and considered it to be an artifact of their isolation procedure. Both Davies and Evans (7) and Barnsley (3) demonstrated that HC...